4-Year PSA Response Rate as a Predictive Measure in Intermediate Risk Prostate Cancer Treated With Ablative Therapies: The Sprat Analysis.

R Glicksman,A U Kishan,A J Katz,C A Mantz,S P Collins,D B Fuller,M L Steinberg,D Shabsovich,L Zhang,D A Loblaw

International journal of radiation oncology, biology, physics（2021）

引用 0|浏览1

暂无评分

摘要

4yPSARR is an encouraging early predictor of outcome in patients with intermediate-risk PCa treated with SBRT. Validation in prospective trials is warranted.

查看译文

关键词

intermediate risk prostate cancer,prostate cancer,sprat analysis

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要